Boston, MA, United States of America

Wai Leung Lau

This inventor holds 1 USPTO granted patent. Top assignee: Aktis Oncology, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wai Leung Lau. Retrieved from https://idiyas.com/inventor/wai-leung-lau

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 17.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Wai Leung Lau

Introduction

Wai Leung Lau is an accomplished inventor based in Boston, MA. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic proteins. His work is characterized by a focus on innovative solutions to complex medical challenges.

Latest Patents

Wai Leung Lau holds a patent for "B7-H3 Miniproteins, Conjugates, and Uses Thereof." This patent represents a notable advancement in the understanding and application of miniproteins in therapeutic contexts. His innovative approach has the potential to impact various treatment modalities.

Career Highlights

Lau is currently employed at Aktis Oncology, Inc., where he continues to push the boundaries of cancer research and treatment. His role at the company allows him to collaborate with other leading experts in the field, further enhancing the impact of his work.

Collaborations

Some of his notable coworkers include William C. Blackwell and Hyun Joo Kil. Their collective expertise contributes to a dynamic research environment that fosters innovation and discovery.

Conclusion

Wai Leung Lau's contributions to biotechnology and his innovative patent work exemplify the spirit of invention. His ongoing efforts at Aktis Oncology, Inc. highlight the importance of collaboration in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…